本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Verrica Pharmaceuticals Inc.

4.45
-0.2000-4.30%
盤後4.530.0800+1.80%19:30 EDT
成交量:11.42萬
成交額:51.76萬
市值:7,644.57萬
市盈率:-2.56
高:4.74
開:4.61
低:4.45
收:4.65
52周最高:9.82
52周最低:3.28
股本:1,717.88萬
流通股本:677.74萬
量比:2.58
換手率:1.68%
股息:- -
股息率:- -
每股收益(TTM):-1.7400
每股收益(LYR):-1.6791
淨資產收益率:-240.35%
總資產收益率:-43.98%
市淨率:17.75
市盈率(LYR):-2.65

資料載入中...

2024/05/13

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/13

重要事件披露

Form 8-K - Current report
2024/02/29

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/08

重要事件披露

Form 8-K - Current report
2023/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/08

重要事件披露

Form 8-K - Current report
2023/07/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities